Genetic factors in the early diagnosis of ALS

References

• Andersen PM, Nilsson P, Keranen M-L et al. Phenotypic het- erogeneity in motor neuron disease patients with CuZn- superoxide dismutase mutations in Scandinavia. Brain 1997; 10: 1723–1737.
   Google Scholar
• Forsgren L, Almay BGL, Holmgren G et al. Epidemiology of motor neuron disease in northern Sweden. Acta Neurol Scand 1983; 68: 20–29.
   PubMed Web of Science ®Google Scholar
• Kurland KT, Mulder DW. Epidemiological investigations of amyotrophic lateral sclerosis. Familial aggregations indicative of dominant inheritance. Parts I & II. Neurology 1955; 5: 182–267.
   Google Scholar
• Williams DB, Floate DA, Leicester J. Familial motor neuron disease: differing penetrance in large pedigrees. J Neurol Sci 1988; 86: 215–230.
   PubMed Web of Science ®Google Scholar
• Suthers G, Laing N, Wilton S et al. ‘Sporadic’ motoneurone disease due to familial SOD1 mutation with low penetrance. Lancet 1994; 344: 1773.
   Google Scholar
• Jones CT, Swingler RJ, Simpson SA et al. Superoxide dismutase mutations in an unselected cohort of Scottish amyotrophic lateral sclerosis patients. J Med Genet 1995; 32: 290–292.
   Google Scholar
• Rosen DR, Siddique T, Pattersson D et al. Mutations in CuZn superoxide dismutase gene are associated with familial amy-otrophic lateral sclerosis. Nature 1993; 364: 59–62.
   Google Scholar
• Cudkowicz ME, McKenna-Yasek D, Chen C et al. Limited corticospinal tract involvement in amyotrophic lateral sclerosis subjects with the A4V mutation in the copper/zinc superoxide dismutase gene. Ann Neurol 1998; 6: 703–710.
   Google Scholar
• Riggio MC, Botti S, Gellera C et al. SOD1 gene: molecular screening in amyotrophic lateral sclerosis Italian families. European Neurological Society Conference, Milan, Italy, June 1999 (abstr.).
   Google Scholar
• Andersen PM, Nilsson P, Ala-Hurula V et al. Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn-superoxide dismutase. Nat Genet 1995; 10: 61–66.
   Google Scholar
• Marklund SL, Andersen PM, Forsgren L et al. Normal binding and reactivity of copper in mutant superoxide dis- mutase isolated from amyotrophic lateral sclerosis patients. J Neurochem 1997; 69: 675–681.
   Google Scholar
• Gurney M, Pu H, Chiu AY et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 1994; 264; 1772–1775.
   Google Scholar
• Robberecht W, Aguirre T, Van den Bosch L et al. D90A het- erozygosity in the SOD1 gene is associated with familial and apparently sporadic amyotrophic lateral sclerosis. Neurology 1996; 47: 1336–1339.
   Google Scholar
• Jackson M, Al-Chalabi A, Enayat ZE et al. Copper/zinc super- oxide dismutase 1 and sporadic amyotrophic lateral scler- osis: analysis of 155 cases and identification of a novel insertion mutation. Ann Neurol 1997; 42: 803–807.
   Google Scholar
• Andersen PM, Forsgren L, Binzer M et al. Autosomal reces- sive adult-onset amyotrophic lateral sclerosis associated with homozygosity for Asp90Ala CuZn-superoxide dismutase mutation. A clinical and genealogical study of 36 patients. Brain 1996; 119: 1153–1172.
   Google Scholar
• Calder VL, Domigan NM, George PM et al. Superoxide dis- mutase (glu100®gly) in a family with inherited motor neuron disease: detection of mutant superoxide dismutase activity and the presence of heterodimers. Neurosci Lett 1995; 189: 143–146.
   Google Scholar
• Hayward C, Minns RA, Swingler RJ et al. Homozygosity of Asn86Ser mutation in the CuZn-superoxide dismutase gene produces a severe clinical phenotype in a juvenile onset case of familial amyotrophic lateral sclerosis. J Med Genet 1998; 2: 174.
   Google Scholar
• Al-Chalabi A, Andersen PM, Chioza B et al. Recessive amyo- trophic lateral sclerosis with the D90A SOD1 mutation share a common founder: evidence for a linked protective factor. Hum Mol Genet 1998; 13: 2045–2050.
   Google Scholar
• Cudkowicz ME, McKenna-Vasek D, Sapp PE et al. Epidemi- ology of mutations in superoxide dismutase in amyotrophic lateral sclerosis. Ann Neurol 1997; 2: 210–211.
   Google Scholar
• Boukaftane Y, Khoris J, Moulard B et al. Identification of six novel SOD1 gene mutations in familial amyotrophic lateral sclerosis. Can J Neurol Sci 1998; 25: 192–196.
   Google Scholar
• Radunovic A, Leigh PN. Cu/Zn superoxide dismutase gene mutations in amyotrophic lateral sclerosis: correlation between genotype and clinical features. J Neurol Neurosurg Psychiatry 1996; 61: 565–572.
   PubMed Web of Science ®Google Scholar
• Ikeda M, Abe K, Aoki M et al. Variable clinical symptoms in familial amyotrophic lateral sclerosis with a novel point mutation in the Cu/Zn superoxide dismutase gene. Neuro- logy 1995; 45: 2038–2042.
   Google Scholar
• Kawata A, Kato S, Hayashi H et al. Prominent sensory and autonomic disturbances in familial amyotrophic lateral sclerosis with a Gly93Ser mutation in the SOD1 gene. J Neurol Sci 1997; 153: 82–85.
   Google Scholar
• Al-Chalabi A, Enayat ZE, Bakker MC et al. Association of apolipoprotein E epsilon 4 allele with bulbar-onset motor neuron disease. Lancet 1996; 347: 159–160.
   Google Scholar
• Moulard B, Sefiani A, Laamri A et al. Apolipoprotein E geno- typing in sporadic amyotrophic lateral sclerosis: evidence for a major influence on the clinical presentation and prognosis. J Neurol Sci 1996; 139 (suppl): 34–37.
   Google Scholar
• Mui S, Rebeck GW, McKenna-Yasek D et al. Apolipoprotein E epsilon 4 allele is not associated with earlier age at onset in amyotrophic lateral sclerosis. Ann Neurol 1995; 38: 460–463.
   Google Scholar
• Smith RG, Haverkamp LJ, Case S et al. Apolipoprotein E epsilon 4 in bulbar-onset motor neuron disease. Lancet 1996; 348: 334–335.
   Google Scholar
• Van Landeghem GF, Tabatabaie P, Beckman L, Beckman G, Andersen PM. Mn-SOD signal sequence polymorphism asso- ciated with sporadic motor neurone disease. Eur J Neurol 1999; 6: 639–644.
   PubMed Web of Science ®Google Scholar
• Al-Chalabi A, Andersen PM, Nilsson P et al. Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis. Hum Mol Genet 1999; 8: 157–164.
   Google Scholar
• Jackson M, Morrison KE, Al-Chalabi A et al. Analysis of chromosome 5q13 genes in amyotrophic lateral sclerosis: homozygous NAIP deletion in a sporadic case. Ann Neurol 1996; 39: 796–800.
   Google Scholar
• Aoki M, Lin CL, Rothstein JD et al. Mutations in the gluta- mate transporter EAAT2 gene do not cause abnormal EAAT2 transcripts in amyotrophic lateral sclerosis. Ann Neurol 1998; 5: 645–653.
   Google Scholar
• Comi GP, Bordoni A, Salani S et al. Cytochrome c oxidase subunit I microdeletion in a patient with motor neuron disease. Ann Neurol 1998; 43: 110–116.
   Google Scholar
• Hayward C, Colville S, Swingler RJ et al. Molecular genetic analysis of the APEX nuclease gene in amyotrophic lateral sclerosis. Neurology 1999; 52: 1899–1901.
   Google Scholar
• Yulug IG, Katsanis N, de Belleroche J et al. An improved protocol for the analysis of SOD1 mutations, and a new mutation in exon 4. Hum Mol Genet 1995; 4: 1101–1104.
   Google Scholar
• Parboosingh JS, Figlewicz DA, Krizus A et al. Spinobulbar muscular atrophy can mimic ALS: the importance of genetic testing in male patients with atypical ALS. Neurology 1997; 49: 568–572.
   Google Scholar
• Rainero I, Pinessi L, Tsuda T et al. SOD1 missense mutation in an Italian family with ALS. Neurology 1994; 44: 347–349.
   Google Scholar
• Haberlandt WF. Genetic aspects of amyotrophic lateral scler- osis and progressive bulbar paralysis. Acta Genet Med Gemellol 1959; 8: 369–373.
   PubMedGoogle Scholar
• Murray TJ, Pride S, Haley G. Motor neuron disease in Nova Scotia. Can Med Assoc J 1974; 110: 814–817.
   PubMed Web of Science ®Google Scholar
• Jokelainen M. Amyotrophic lateral sclerosis in Finland. II: Clinical characteristics. Acta Neurol Scand 1977; 56: 194–204.
   PubMed Web of Science ®Google Scholar
• Rosen AD. Amyotrophic lateral sclerosis. Clinical features and prognosis. Arch Neurol 1978; 35: 638–642.
   PubMed Web of Science ®Google Scholar
• Giagheddu M, Puggioni G, Masala C et al. Epidemiologic study of amyotrophic lateral sclerosis in Sardinia, Italy. Acta Neurol Scand 1983; 68: 394–404.
   Google Scholar
• Li TM, Alberman E, Swash M. Comparison of sporadic and familial disease amongst 580 cases of motor neuron disease. J Neurol Neurosurg Psychiatry 1988; 51: 778–784.
   PubMed Web of Science ®Google Scholar
• Hojer-Pedersen E, Christensen PB, Jensen NB. Incidence and prevalence of motor neuron disease in two Danish counties. Neuroepidemiology 1989; 8: 151–159.
   PubMed Web of Science ®Google Scholar
• Murros K, Fogelholm R. Amyotrophic lateral sclerosis in Middle-Finland: an epidemiological study. Acta Neurol Scand 1983; 67: 41–47.
   PubMed Web of Science ®Google Scholar
• Haverkamp LJ, Appel V, Appel SH. Natural history of amyo- trophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain 1995; 118: 707–719.
   Google Scholar
• Fong KY, Yu YL, Chan YW et al. Motor neuron disease in Hong Kong Chinese: epidemiology and clinical picture. Neuroepidemiology 1996; 15: 239–245.
   Google Scholar
• Juneja T, Pericak-Vance MA, Laing NG et al. Prognosis in familial amyotrophic lateral sclerosis: progression and sur- vival in patients with glu100gly and ala4val mutations in Cu,Zn-superoxide dismutase. Neurology 1997; 48: 55–57.
   Google Scholar
• Emery AEH, Holloway S. Familial motor neurone diseases. In: Rowland LP, Ed. Human Motor Neurone Diseases. New York: Raven Press, 1982: 139–145.
   Google Scholar
• Belleroche J, Orrell R, King A. Familial amyotrophic lateral sclerosis/motor neurone disease (FALS): a review of current developments. J Med Genet 1995; 32: 841–847.
   PubMed Web of Science ®Google Scholar
• Orrell RW, Marklund SL, de Belleroche JS. Familial ALS is associated with mutations in all exons of SOD1: a novel mutation in exon 3 (Gly72Ser). J Neurol Sci 1997; 153: 46–49.
   PubMed Web of Science ®Google Scholar
• Shaw CE, Enayat ZE, Chioza BA et al. Mutations in all five exons of SOD-1 may cause ALS. Ann Neurol 1998; 43: 390–394.
   Google Scholar